EMA Authorised: Acvybra (denosumab) — Reddy Holding GmbH

View source ↗

Summary

The European Medicines Agency has authorised Acvybra (denosumab) from Reddy Holding GmbH for osteoporosis-related conditions, including postmenopausal osteoporo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Acvybra (denosumab)

Snippet

Status: Authorised. Therapeutic area: Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal. MAH: Reddy Holding GmbH. Decision date: 17/11/2025